NHS National Framework for Transition products commencing 1 October 2024

NHS England · Awarded

Buyer
NHS England
Status
Awarded
Country
United Kingdom
Region
England
Sector
Manufacturing
Reference
FaT-ocds-h6vhtk-0472c3
Published
2024-10-17
Deadline
2026-04-18

Tender summary

Project title: NHS National Framework for Transition products commencing 1 October 2024 Offer reference number: CM/TNS/24/5712 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months. Potential periods of call-offs under the framework agreement: CM/TNS/24/5712/01 - Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets Lot 1 CESW: 01/10/2024 to 30/09/2025 (12 months) Lot 2 NWLN: 01/10/2024 to 30/09/2025 (12 months) Lot 3 LSNE:…

This is a public summary of a procurement notice. Dates and status reflect the notice held by BidScout; check the full notice before bidding.

Full tender details have a three-minute guest preview for open opportunities. AI insights require registration.

Register for full access

IT tenders · Construction tenders · Sitemap